tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:NTI Stock Latest News

Neurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164
Company AnnouncementsNeurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164
4d ago
NTI
Neurotech Advances Lead Paediatric Neurology Drug NTI164 with New FDA Designation, Data and Funding
PremiumCompany Announcements
Neurotech Advances Lead Paediatric Neurology Drug NTI164 with New FDA Designation, Data and Funding
7d ago
NTI
Neurotech’s NTI164 PANS Data Published in Leading Journal, Bolstering Paediatric Neuro Portfolio
PremiumCompany Announcements
Neurotech’s NTI164 PANS Data Published in Leading Journal, Bolstering Paediatric Neuro Portfolio
22d ago
NTI
Neurotech Issues New Shares, Affirms Regulatory Compliance
PremiumCompany Announcements
Neurotech Issues New Shares, Affirms Regulatory Compliance
1M ago
NTI
Neurotech Seeks ASX Quotation for 246.7 Million New Shares
PremiumCompany Announcements
Neurotech Seeks ASX Quotation for 246.7 Million New Shares
1M ago
NTI
Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
PremiumCompany AnnouncementsNeurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
1M ago
NTI
Neurotech Options Lapse, Streamlining Capital Structure
Premium
Company Announcements
Neurotech Options Lapse, Streamlining Capital Structure
1M ago
NTI
Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments
Premium
Company Announcements
Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments
2M ago
NTI
Neurotech International Initiates Trading Halt for Capital Raising Announcement
PremiumCompany Announcements
Neurotech International Initiates Trading Halt for Capital Raising Announcement
2M ago
NTI
Neurotech International’s AGM Reflects Strong Shareholder Support
PremiumCompany Announcements
Neurotech International’s AGM Reflects Strong Shareholder Support
3M ago
NTI
Neurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements
PremiumCompany Announcements
Neurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements
3M ago
NTI
Neurotech Expands NTI164 Access and Gains FDA Designation
PremiumCompany Announcements
Neurotech Expands NTI164 Access and Gains FDA Designation
3M ago
NTI
Neurotech International Announces 2025 Annual General Meeting
PremiumCompany AnnouncementsNeurotech International Announces 2025 Annual General Meeting
4M ago
NTI
Neurotech International Releases 2025 Annual Report
Premium
Company Announcements
Neurotech International Releases 2025 Annual Report
4M ago
NTI
Neurotech Secures FDA Rare Pediatric Disease Designation for Rett Syndrome Drug
Premium
Company Announcements
Neurotech Secures FDA Rare Pediatric Disease Designation for Rett Syndrome Drug
4M ago
NTI
Neurotech Launches Authorised Prescriber Program for NTI164
PremiumCompany Announcements
Neurotech Launches Authorised Prescriber Program for NTI164
5M ago
NTI
Neurotech International Strengthens Corporate Governance Framework
PremiumCompany Announcements
Neurotech International Strengthens Corporate Governance Framework
5M ago
NTI
Neurotech International Reports Increased Losses Amid Revenue Decline
PremiumCompany Announcements
Neurotech International Reports Increased Losses Amid Revenue Decline
5M ago
NTI
Neurotech International Advances NTI164 with Promising Study Results
PremiumCompany Announcements
Neurotech International Advances NTI164 with Promising Study Results
6M ago
NTI
Neurotech International Relocates Headquarters to Melbourne
PremiumCompany AnnouncementsNeurotech International Relocates Headquarters to Melbourne
7M ago
NTI
Maybank Securities Becomes Substantial Holder in Neurotech International
Premium
Company Announcements
Maybank Securities Becomes Substantial Holder in Neurotech International
7M ago
NTI
Neurotech’s Rett Syndrome Trial Results Published in Scientific Journal
Premium
Company Announcements
Neurotech’s Rett Syndrome Trial Results Published in Scientific Journal
7M ago
NTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >